ArticleFrontiers in immunology2024

Efficacy and safety evaluation of cross-reactive Fibroblast activation protein scFv-based CAR-T cells.

Wenhao Niu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.